The DOI matches its Crossref record; 765 of the 770 references it cites were found in a registry or an index.
The epigenetics of aging and neurodegeneration
Open accessAbstract
Epigenetics is a quickly growing field encompassing mechanisms regulating gene expression that do not involve changes in the genotype. Epigenetics is of increasing relevance to neuroscience, with epigenetic mechanisms being implicated in brain development and neuronal differentiation, as well as in more dynamic processes related to cognition. Epigenetic regulation covers multiple levels of gene expression; from direct modifications of the DNA and histone tails, regulating the level of transcription, to interactions with messenger RNAs, regulating the level of translation. Importantly, epigenetic dysregulation currently garners much attention as a pivotal player in aging and age-related neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, where it may mediate interactions between genetic and environmental risk factors, or directly interact with disease-specific pathological factors. We review current knowledge about the major epigenetic mechanisms, including DNA methylation and DNA demethylation, chromatin remodeling and non-coding RNAs, as well as the involvement of these mechanisms in normal aging and in the pathophysiology of the most common neurodegenerative diseases. Additionally, we examine the current state of epigenetics-based therapeutic strategies for these diseases, which either aim to restore the epigenetic homeostasis or skew it to a favorable direction to counter disease pathology. Finally, methodological challenges of epigenetic investigations and future perspectives are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the cellular heterogeneity of the AD brain presents significant analytical hurdles. Advanced computational deconvolution techniques or experimental methods such as fluorescence-activated cell sorting (FACS) are often required to resolve distinct cell populations, including neurons, astrocytes, and microglia127,157.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Dönmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 443
RetractedLiang, Q., Fujita, R., Yamashita, T., Angulo, S. L., Rhinn, H., Rhee, D. B., Doege, C. A., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 231
RetractedKAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling
Kaidi, A., & Jackson, S. P. (2013) · Nature · doi:10.1038/nature12201 · Cited by 167
RetractedKuhn, D. E., Nuovo, G. J., Terry, A. V., Martin, M. M., Malana, G. E., Sansom, S. E., Pleister, A. P., Beck, W. D., Head, E., Feldman, D. S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033407 · Cited by 121
RetractedInitial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Research works printed but not linked: 2
- Alarcón, 2004, Chromatin acetylation, memory, and LTP are impaired in CBP+/− mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration, Neuron, 42, 947, 10.1016/j.neuron.2004.05.021 · DOI · Paper page
- Lovestone, 1997, The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes, Neuroscience, 78, 309
Cited by
Sorted by citations
Items 201–300 of 390
Ionescu-Tucker, A., Butler, C., Berchtold, N. C., Matheos, D. P., Wood, M. A., & Cotman, C. W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.798297 · Cited by 15
Kim, J. J., Daadi, E. W., Oh, T. T., Daadi, E. S., & Daadi, M. M. (2022) · Genes · doi:10.3390/genes13111937 · Cited by 14
Systematic analysis of genetic variants in Han Chinese patients with sporadic Parkinson’s disease
Yuan, L., Song, Z. J., Deng, X., Zheng, W., Guo, Y., Yang, Z., & Deng, H. (2016) · Scientific Reports · doi:10.1038/srep33850 · Cited by 15
Song, Y., Liu, Y., Wu, P., Zhang, F., & Wang, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-30624-1 · Cited by 15
Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis
Robichaud, P.-P., Arseneault, M., O’Connell, C. M., Ouellette, R. J., & Morin, P. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135813 · Cited by 15
Pan, L., Zhu, J., Wang, S., Zhuang, H., Zhang, S., Huang, Z., Cai, F., Song, Z., Liu, Y., Liu, W., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105829 · Cited by 16
Octodon degus: a natural model of multimorbidity for ageing research
Cuenca‐Bermejo, L., Pizzichini, E., Cuello, A. M. G., Stefano, M. E. D., Fernández‐Villalba, E., & Herrero, M. T. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101204 · Cited by 14
Photoperiod‐induced neurotransmitter plasticity declines with aging: An epigenetic regulation?
Pritchard, R. A., Chen, H., Romoli, B., Spitzer, N. C., & Dulcis, D. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24747 · Cited by 14
Aspects of the immune system that impact brain function
Bondy, S. C. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577167 · Cited by 14
González-Mundo, I., Pérez-Vielma, N. M., Gómez‐López, M., Fleury, A., Correa‐Basurto, J., Rosales‐Hernández, M. C., Sixto‐López, Y., Martínez–Godínez, M. D. L. Á., Domínguez‐López, A., & Miliar-García, Á. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110951 · Cited by 14
Epigenetic Drug Discovery for Alzheimer’s Disease
Cacabelos, R., & Teijido, Ó. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811060-7.00022-x · Cited by 14
Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics
Cacabelos, R., Carrera, I., Martínez, O., Alejo, R., Fernández‐Novoa, L., Cacabelos, P., Corzo, L., Rodríguez, S., Alcaraz, M., Nebril, L., et al. (2021) · Medicinal Research Reviews · doi:10.1002/med.21838 · Cited by 14
Epigenetic modifications in Parkinson's disease: A critical review
Sharma, R., Bisht, P., Kesharwani, A., Murti, K., & Kumar, N. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176641 · Cited by 14
Morales-Lara, D., De‐la‐Peña, C., & Murillo‐Rodríguez, E. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0409-6 · Cited by 13
Ribeiro, H. F., Santos, J. S. F. D., & Souza, J. N. D. (2021) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v84i2.3998 · Cited by 16
Current and Near-Future Treatment of Alzheimer’s Disease
Gąsiorowski, K., Brokos, B., Sochocka, M., Ochnik, M., Chojdak-Łukasiewicz, J., Zajączkowska, K., Fułek, M., & Leszek, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666211202124239 · Cited by 13
Baronchelli, S., Spada, A., Ntai, A., Barbieri, A., Conforti, P., Jotti, G. S., Redaelli, S., Bentivegna, A., Blasio, P. D., & Biunno, I. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.04.013 · Cited by 13
Cooperative Effects of Cytosine Methylation on DNA Structure and Dynamics
Hognon, C., Besancenot, V., Gruez, A., Grandemange, S., & Monari, A. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b05835 · Cited by 13
Chinn, C. A., Ren, H., Morival, J. L. P., Nie, Q. H., Wood, M. A., & Downing, T. L. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.08.006 · Cited by 14
Targeting neuronal epigenomes for brain rejuvenation
Zocher, S. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00148-8 · Cited by 13
Khan, M. A., Haider, N., Singh, T., Bandopadhyay, R., Ghoneim, M. M., Alshehri, S., Taha, M., Ahmad, J., & Mishra, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01180-z · Cited by 12
Steyaert, S., Diddens, J., Galle, J., Meester, E. D., Keulenaer, S. D., Bakker, A., Sohnius‐Wilhelmi, N., Frankl‐Vilches, C., der Linden, A. V., Criekinge, W. V., et al. (2016) · Scientific Reports · doi:10.1038/srep20957 · Cited by 12
CEST‐2.2 overexpression alters lipid metabolism and extends longevity of mitochondrial mutants
Piazzesi, A., Wang, Y. A., Jackson, J., Wischhof, L., Zeisler-Diehl, V. V., Scifo, E., Oganezova, I., Hoffmann, T., Martín, P. G., Bertan, F., et al. (2022) · EMBO Reports · doi:10.15252/embr.202152606 · Cited by 11
Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models
Créau, N., Cabet, É., Daubigney, F., Souchet, B., Bennaï, S., & Delabar, J. M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.003 · Cited by 13
Rossetti, M. F., Schumacher, R., Lazzarino, G. P., Gómez, A. L., Varayoud, J., & Ramos, J. G. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.01.025 · Cited by 12
Epigenomic Remodeling in Huntington’s Disease—Master or Servant?
Zimmer‐Bensch, G. (2020) · Epigenomes · doi:10.3390/epigenomes4030015 · Cited by 12
Choi, D., Murali, S., Kwon, W., Woo, J., Song, E. C., Ko, Y., Sardar, D., Lozzi, B., Cheng, Y.-T., Williamson, M. R., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02115-w · Cited by 12
Marei, H. E. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05590-1 · Cited by 13
Aetiology and pathophysiology of neurodegenerative disorders
Sahoo, R. K., Gupta, T., Smily, Kumar, V., Rani, S., & Gupta, U. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00006-x · Cited by 13
Roles for c-Abl in postoperative neurodegeneration
Feng, L., Fu, S., Yao, Y., Li, Y., Xu, L., Zhao, Y., & Luo, L. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.73740 · Cited by 12
Escarcega, R. D., J., V. K. M., Kyriakopoulos, V. E., Ortiz, G. J., Gusdon, A. M., Fan, H., Peesh, P., Conesa, M. P. B., Colpo, G. D., Ahnstedt, H. W., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106747 · Cited by 11
Paul, B., & Tollefsbol, T. O. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00002-4 · Cited by 10
Challenges and (Un)Certainties for DNAm Age Estimation in Future
Dias, H. C., Cunha, E. M., Real, F. C., & Manco, L. (2022) · Forensic Sciences · doi:10.3390/forensicsci2030044 · Cited by 14
Kretzschmar, G. C., Targa, A., Soares‐Lima, S. C., dos Santos, P. I., Rodrigues, L. S., Macedo, D. A., Pinto, L. F. R., Lima, M. M. S., & Boldt, A. B. W. (2022) · Genes · doi:10.3390/genes13122397 · Cited by 10
Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients
McClarty, B. M., Fisher, D. W., & Dong, H. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0134-4 · Cited by 10
Fisher, D. W., Tulloch, J., Yu, C., & Tsuang, D. W. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr220114 · Cited by 9
Mai, H. A., Thomas, C. M., Nge, G. G., & Elefant, F. (2025) · Cells · doi:10.3390/cells14120873 · Cited by 10
Ferroptosis and Alzheimer’s disease: a new insight into neurodegeneration
Quan, Y., Liu, H., Zhang, M., Li, M., He, B., Wang, K., Huang, X., Zhou, S., Han, Z., & Fan, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1701767 · Cited by 11
Bouter, Y., Kacprowski, T., Rößler, F., Jensen, L. R., Kuss, A. W., & Bayer, T. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580524 · Cited by 10
Gene Therapy for Alzheimer and Parkinson Diseases
Saad, J. F., & Saad, F. A. (2023) · Current Gene Therapy · doi:10.2174/1566523223666230419101023 · Cited by 9
DNA Homeostasis and Senescence: Lessons from the Naked Mole Rat
Boughey, H., Jurga, M., & El‐Khamisy, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116011 · Cited by 10
Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice
Chouliaras, L., Lardenoije, R., Kenis, G., Mastroeni, D., Hof, P. R., van Os, J., Steinbusch, H. W. M., van Leeuwen, F. W., Rutten, B. P. F., & van den Hove, D. (2018) · Translational Neuroscience · doi:10.1515/tnsci-2018-0028 · Cited by 10
Self-citationFigueiredo, A. I., da Cunha, J. J., da Silva, I. R. V., Martins, L. L., Bard, A. L., Reinaldo, G. P., Elsner, V. R., & de Souza, M. P. (2017) · Middle East Journal of Rehabilitation and Health Studies · doi:10.5812/mejrh.57486 · Cited by 9
Functional Implications of Dynamic DNA Methylation for the Developing, Aging and Diseased Brain
Zimmer‐Bensch, G. (2019) · RNA technologies · doi:10.1007/978-3-030-14792-1_6 · Cited by 8
Olasehinde, T. A., Ekundayo, T. C., Okaiyeto, K., & Olaniran, A. O. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01101-z · Cited by 9
Advances in Drug Discovery and Development in Geriatric Psychiatry
Conley, A. C., & NEWHOUSE, P. A. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0871-5 · Cited by 8
A coarse-grained DNA model to study protein-DNA interactions and liquid-liquid phase separationPreprint
Kapoor, U., Kim, Y. C., & Mittal, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.19.541513 · Cited by 7
Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies
Reho, P., Sáez-Atiénzar, S., Ruffo, P., Solaiman, S., Shah, Z., Chia, R., Kaivola, K., Traynor, B. J., Tilley, B. S., Gentleman, S., et al. (2024) · Communications Biology · doi:10.1038/s42003-023-05725-x · Cited by 6
Kastberger, B., Winter, S., Brandstaetter, H., Biller, J., Wagner, W., & Plesnila, N. (2023) · Advanced Biology · doi:10.1002/adbi.202300439 · Cited by 6
Macías, M., Alba‐Linares, J. J., Acha, B., Blanco‐Luquin, I., Fernández, A. F., Álvarez-Jiménez, J., Urdánoz‐Casado, A., Roldán, M., Robles, M., Cabezon-Arteta, E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073419 · Cited by 7
Luise, C., & Robaa, D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8630-9_21 · Cited by 6
Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy
Li, L.-H., Huang, Y., Wang, X., Xu, C.-C., Wu, L., He, K.-L., Han, D., Chang, Z., Wang, J., & Ma, R.-J. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2634566 · Cited by 5
DNA Methylation in Neurodegenerative Diseases
Fedotova, E. Y., & Illarioshkin, S. N. (2019) · Russian Journal of Genetics · doi:10.1134/s1022795419030062 · Cited by 5
Nurkolis, F., Utami, T. W., Alatas, A. I., Wicaksono, D., Kurniawan, R., Ratmandhika, S. R., Sukarno, K. T., Pahu, Y. G. P., Kim, B., Tallei, T. E., et al. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1462569 · Cited by 5
Genetic, Biochemical and Histopathological Aspects of Familiar Alzheimer's Disease
Ortíz, G. G., Pacheco-Moisés, F. P., González-Renovato, E. D., Figuera, L. E., Macías-Islas, M. Á., Mireles-Ramírez, M. A., Flores-Alvarado, L. J., Sánchez-López, A. L., Nuño-Penilla, D. G., Velázquez-Brizuela, I. E., et al. (2015) · InTech eBooks · doi:10.5772/59809 · Cited by 5
Stem Cell Technology for (Epi)genetic Brain Disorders
Riemens, R. J. M., Soares, E. S., Esteller, M., & Delgado‐Morales, R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_23 · Cited by 6
Lardenoije, R., van den Hove, D., Jung, S. E., Havermans, M., Blackburn, P., Liu, B., Rutten, B. P. F., & Lemere, C. A. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190827122009 · Cited by 5
Self-citationReynolds, V. L., Butler, P., Abernathy, M. M., Aschenbrenner, L. M., Best, D. D., Blank, J., Crosby, M. E., Custer, L. L., Escobar, P. A., Kolaja, K. L., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104746 · Cited by 5
Age- and disease-related memory decline: epigenetic biomarker and treatment
Zhang, J., & Liu, Q. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.07.040 · Cited by 5
Li, T., Hou, X., Chen, Z., Peng, Y., Wang, P., Xie, Y., He, L., Yuan, H., Peng, H., Qiu, R., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00566 · Cited by 5
Paul, J. L., Dashtipour, K., Chen, Z., & Wang, C. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz028 · Cited by 5
Neurodegeneration and aging: pathophysiology, diagnosis, and therapeutic targets
Thakur, A., Sharma, R., Sharma, R. R., & Devi, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01991-9 · Cited by 4
Histone and non-histone (de)acetylation impact on the blood-brain barrier
Melo, M., Fortuna, A. C., Laranjinha, J. A. N., & Bicker, J. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00763-z · Cited by 5
Oljačić, S., Popovic-Nikolic, M., Filipić, B., Gagić, Ž., & Nikolic, K. M. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266337668241025061804 · Cited by 5
Zhang, Q., Kong, W., Yuan, J., Chen, Q., Gong, C., Liu, L., Wang, F., Huang, J., Yang, G., Zhou, K., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.639656 · Cited by 4
Guo, X., Dong, Y., & Zhang, X. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1800507 · Cited by 4
DNA methylation in Parkinson disease
Iakovenko, E. V., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Annals of Clinical and Experimental Neurology · doi:10.25692/acen.2020.4.10 · Cited by 4
Ionescu-Tucker, A., Tong, L., Berchtold, N. C., & Cotman, C. W. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.796087 · Cited by 4
Riemens, R. J. M., Kenis, G., Nolz, J., Chaves, S. C. S., Duroux, D., Pishva, E., Mastroeni, D., Steen, K. V., Haaf, T., & van den Hove, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415571 · Cited by 4
Self-citationHISTORY, EPIDEMIOLOGY, AND PUTATIVE MOLECULAR BASIS OF AUTISM SPECTRUM DISORDER
Alharbi, M. G. (2023) · Applied Ecology and Environmental Research · doi:10.15666/aeer/2101_805821 · Cited by 4
Bayón, A. R., & Sampedro, F. G. (2018) · Neurología (English Edition) · doi:10.1016/j.nrleng.2017.01.011 · Cited by 4
High Expression of JMJD4 Is a Potential Diagnostic and Prognostic Marker of Renal Cell Carcinoma
Yan, H., Bao, Y., & Lin, Z. (2021) · Disease Markers · doi:10.1155/2021/9573540 · Cited by 4
Epigenetic targets for the treatment of neurodegenerative diseases
Peedicayil, J. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.323 · Cited by 4
Daily, K. P., Badr, A., Eltobgy, M. M., Estfanous, S. Z. K., Whitham, O. D., Tan, M. H., Carafice, C., Krause, K., McNamara, A. J., Hamilton, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555526 · Cited by 4
Beyond the Genotype: A Multi-Omic Analysis of APOEe4’s Role in Alzheimer’s DiseasePreprint
Markov, Y., Priyanka, A., Xu, L., Wang, W., Thrush, K., González, J. T., Borrus, D. S., Kasamoto, J., Sehgal, R., Zou, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.16.682426 · Cited by 4
Deciphering and manipulating the epigenome for the treatment of Parkinson’s and Alzheimer’s disease
Okechukwu, C. E. (2021) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_90_20 · Cited by 3
Tripathi, S., & Bhawana, B. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04167-z · Cited by 4
Ghanem, A. S., Móré, M., & Nagy, A. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062382 · Cited by 3
Depression and associated Alzheimer’s disease
Patil, N. P., & Gupta, G. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00027-x · Cited by 3
Radenković, D., Zhavoronkov, A. A., & Bischof, E. Y. (2021) · Springer eBooks · doi:10.1007/978-3-030-58080-3_248-1 · Cited by 4
Shea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3
Naidoo, V., Martínez-Iglesias, O. A., & Cacabelos, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00012-5 · Cited by 3
Halder, A. K., Moura, A. S., & Cordeiro, M. N. D. S. (2018) · Methods in pharmacology and toxicology · doi:10.1007/7653_2018_14 · Cited by 3
Dual effects of S-adenosyl-methyonine on PC12 cells exposed to the dopaminergic neurotoxin MPP+
Cantelmo, R. A., dos Santos, N. A. G., dos Santos, A. C., & Joca, S. R. L. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13323 · Cited by 3
The caloric restriction fallacy, rodent diet aids and the tumor suppression theory of agingPreprint
Wolf, A. M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/a2689 · Cited by 2
Development of a Peptide Inhibitor To Prevent Alpha-Synuclein Fibrillization in Parkinson’s Disease
Jabbari, A., Niknejad, A., Fard, N. A., Karami, L., & Motamedi, M. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10728-9 · Cited by 2
Zainuddin, M.-S., Ghanesh, K., Ganesan, N., Kumari, M., Radhakrishnan, A. K., & Bhuvanendran, S. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2526155 · Cited by 2
Yin, L., Yin, M., Fan, Z., Shi, Y.-X., Shan, J., Wang, L., Chen, Y., Hao, C., Zhuang, T., Liu, T., et al. (2026) · Bioorganic chemistry (Print) · doi:10.1016/j.bioorg.2026.109785 · Cited by 2
Sivalingam, A. M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05981-y · Cited by 2
Prenatal Influences on Cognitive Aging
de Rooij, S. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108552684.027 · Cited by 2
The role of noncoding RNAs in pancreatic birth defects
Yang, Z., & Parchem, R. J. (2023) · Birth Defects Research · doi:10.1002/bdr2.2178 · Cited by 2
Koyu, H., İstanbullu, H., Turunç, E., & Temiz, T. K. (2023) · European Food Research and Technology · doi:10.1007/s00217-023-04424-5 · Cited by 2
Hendricks, E. L., Linskey, N., Smith, I. R., & Liebl, F. L. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158429 · Cited by 2
Zhang, Y., Mao, Y., Fu, Q.-Q., Zhang, X., Zhang, D., Yue, Y., & Yang, C. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1414603 · Cited by 2
Schumacher, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805388-1.00025-0 · Cited by 2
Dmitry, P. I. (2021) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819487-4.00018-5 · Cited by 2
Bera, I. (2018) · Current Signal Transduction Therapy · doi:10.2174/1574362413666180312125419 · Cited by 2
Advancements in Brain Lymphatic System and Its Involvement in Neurological Diseases
Bari, D., Das, U., Shevalkar, G. B., Kapadia, R., Singhai, V., & Pardeshi, C. V. (2024) · Springer eBooks · doi:10.1007/978-3-031-64828-1_2 · Cited by 2
Costi, C., Menta, G., Fiorito, G., & D’Ambrosio, C. (2025) · Economics & Human Biology · doi:10.1016/j.ehb.2025.101509 · Cited by 2
Molecular pathways and biomarkers associated with age-related cognitive decline
Mitra, S., Pandey, S., Gill, A., Roy, A., Dutta, S., Kumar, A., Ali, M., & Chawla, G. (2025) · Academia Biology · doi:10.20935/acadbiol7909 · Cited by 2
Metadata
- Authors
- Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., & Rutten, B. P. F.
- Affiliations
- Maastricht University (NL)
- University of Lausanne (CH)
- Banner Sun Health Research Institute (US)
- Brigham and Women's Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Rutten, Bart P.F.
- ORCID
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 131
- Pages
- 21-64
- ISSN
- 0301-0082 (ISSN-L)
- PMC
- PMC6477921
- OpenAlex
- W648684004
- Cited by
- 381
- References
- 770
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 28 · 2023: 28 · 2022: 32 · 2021: 47 · 2020: 30 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 11
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Internationale Stichting Alzheimer Onderzoek (07551, 11532, 09552, 13515)
- Netherlands Organization for Scientific Research (916.11.086)
- National Institutes of Health (P50 AG005138)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- epigenetics, aging, neurodegeneration, DNA methylation, DNA demethylation, chromatin remodeling, non-coding RNA, Alzheimer's disease, Parkinson's disease, Huntington's disease, epigenetic therapy, gene expression regulation, histone modifications
- MeSH terms
- Aging, Animals, Humans, DNA Methylation, Neurodegenerative Diseases, Genetic Predisposition to Disease, RNA, Untranslated, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review